CoChat

Severe Hepatotoxicity During Valproate Therapy: An Update and Report of Eight New Fatalities

St. König, A., Siemes, H., Bläker, F., Boenigk, E., Groß‐Selbeck, G., Hanefeld, F., Haas, N., Köhler, B., Koelfen, W., Korinthenberg, R., Kurek, E., Lenard, H‐G., Penin, H., Penzien, J.M., Schünke, W., Schultze, C., Stephani, U., Stute, M., Traus, M., Weinmann, H.‐M., Scheffner, W. · 1994 · Epilepsia
Cited by 136

The DOI matches its Crossref record.

Abstract

Summary: Since our last report on valproate (VPA)‐related hepatotoxicity in 1988, 8 other children have died of VPA‐associated liver failure in Germany and Switzerland. We compared the clinical course of these children with that of 6 children with a reversible outcome of severe hepatotoxicity related to VPA. Thirty‐five percent of patients with fatal liver failure were normally developed, 23.5% were receiving VPA monotherapy, and 35·3% were aged s2 years. The initial clinical symptoms of VPA‐related hepatotoxicity were nausea, vomiting, apathy or coma, and increasing seizures in more than 50% of patients, in combination with febrile infections at onset of symptoms. As compared with the series of German patients reported in 1988, one third of the fatalities occurred after the first 6 months of therapy as compared with 6% in the 1988 series. Clinical symptoms and laboratory findings were the same in patients with reversible and with fatal outcome. Early or immediate withdrawal of VPA after the first signs of VPA‐associated hepatotoxicity may be responsible for the increased number of children who recovered after VPA‐related severe liver failure. The pathogenesis of liver failure during VPA treatment remains unknown; metabolic defects and cofactors such as polypharmacy or infections have become increasingly likely to contribute by depleting intracellular CoA. Worldwide, 132 patients have died of VPA‐associated liver failure and/or pancreatitis. Because a group at risk for fatalities with VPA cannot be defined precisely, patients treated with VPA and their families must be made well aware of the clinical symptoms of hepatotoxicity such as apathy, vomiting, or increased seizure frequency, especially in the presence of febrile infections. Laboratory tests and clinical controls during the first 6 months of therapy should not be neglected.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1157.1994.tb02546.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 136

Metadata

Authors
St. König, A., Siemes, H., Bläker, F., Boenigk, E., Groß‐Selbeck, G., Hanefeld, F., Haas, N., Köhler, B., Koelfen, W., Korinthenberg, R., Kurek, E., Lenard, H., Penin, H., Penzien, J. M., Schünke, W., Schultze, C., Stephani, U., Stute, M., Traus, M., Weinmann, H. ‐., & Scheffner, W.
Venue
Epilepsia
Publisher
Wiley
Published
1994-09
Volume
35
Issue
5
Pages
1005-1015
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1964742452
Cited by
136
References
0
FWCI
8.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severe Hepatotoxicity During Valproate Therapy: An Update and Report of Eight New Fatalities. https://app.cochat.ai/papers/10.1111/j.1528-1157.1994.tb02546.x
The paper
St. König, A., Siemes, H., Bläker, F., Boenigk, E., Groß‐Selbeck, G., Hanefeld, F., Haas, N., Köhler, B., Koelfen, W., Korinthenberg, R., Kurek, E., Lenard, H., Penin, H., Penzien, J. M., Schünke, W., Schultze, C., Stephani, U., Stute, M., Traus, M., . . . Scheffner, W. (1994). Severe Hepatotoxicity During Valproate Therapy: An Update and Report of Eight New Fatalities. Epilepsia. https://doi.org/10.1111/j.1528-1157.1994.tb02546.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.